CONTENTS:
- Revisiting the effect of recreational marijuana on traffic fatalities. Adhikari K., Maas A., Trujillo-Barrera A., art. 104000.
- Trends in drug use among nightclub and festival attendees in New York City, 2017-2022. Palamar J.J., Le A., Cleland C.M., Keyes K.M., art. 104001.
- 'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue. Clay S., Treloar C., Degenhardt L., Grebely J., Christmass M., Gough C., et al., art. 104002.
- Minimum legal age laws and perceived access to cigarettes, e-cigarettes, and other substances among youth in Canada, England, and the United States: 2017-2021. Reid J.L., Burkhalter R., Kasza K., Seo Y.S., East K., Hyland A., et al., art. 104003.
- "Another tool in the toolkit" - Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site. Perlmutter D., Wettemann C., Fockele C.E., Frohe T., Williams W., Holland N., et al., art. 104005.
- "Harm per litre" as a concept and a measure in studying determinants of relations between alcohol consumption and harm. Room R., Rehm J., art. 104006.
- Income inequality and daily use of cannabis, cigarettes, and e-cigarettes among Canadian secondary school students: Results from COMPASS 2018-19. Benny C., Steele B.J., Patte K.A., Leatherdale S.T., Pabayo R., art. 104014.
- Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops. Nielsen S., Barratt M., Hiley S., Bartlett M., Latimer J., Jauncey M., et al., art. 104015.
- Exploring correlates of support for restricting breast cancer awareness marketing on alcohol containers among women. Greene N.K., Rising C.J., Seidenberg A.B., Eck R., Trivedi N., Oh A.Y., art. 104016.
- Assessing options for poppers policy in Canada: A call to action for evidence-based policy reform. Schwartz C., Card K., Elliott R., Hollett K., Jollimore J., Pasic A., et al., art. 104017.
- Re-incarceration and associated social, structural and behavioural factors among people who use drugs in an urban Canadian setting. Brooks O., Hayashi K., Cui Z., Milloy M.J., Kerr T., Fairbairn N., art. 104018.
- From Anti-doping-I to Anti-doping-II: Toward a paradigm shift for doping prevention in sport. McLean S., Naughton M., Kerhervé H., Salmon P.M., art. 104019.
- Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting. Holmén E., Hammarberg A., Kaberg M., Storbjörk J., art. 104021.
- Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies. Giang K., Charlesworth R., Thulien M., Mulholland A., Barker B., Brar R., et al., art. 104023.
- Drug use before and during imprisonment: Drivers of continuation. Favril L., art. 104027.